M1 Kliniken - Public Comps and Valuation Multiples

M1 Kliniken Overview

About M1 Kliniken

M1 Kliniken AG is a healthcare company operating in the market for aesthetic medical treatment and plastic surgery. It operates through Beauty and Trade segments. Its activities are focused on providing aesthetic medical treatment. In addition to medical aesthetic treatments, the company also develops and markets pharmaceutical, medical, and medical technology products for aesthetic surgery and cosmetic dermatology. Some of the treatments offered by the group are lip under injection, eyebrow lift, tummy tuck, breast reduction, sweat treatment, liposuction, and others. The organization conducts its business operations in Germany. The majority of its revenue is derived from the Trade segment.

Founded

2007

HQ

Employees

219

Website

m1-kliniken.de

Sectors

Hospitals & Clinics

Financials

LTM Revenue $394M

LTM EBITDA $35.6M

EV

$336M

Valuation Multiples

Multiples.vc

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

M1 Kliniken Financials

M1 Kliniken has a last 12-month revenue of $394M and a last 12-month EBITDA of $35.6M.

In the most recent fiscal year, M1 Kliniken achieved revenue of $360M and an EBITDA of $26.3M.

M1 Kliniken expects next 12-month revenue of XXX and NTM EBITDA of XXX

See M1 Kliniken valuation multiples based on analyst estimates

M1 Kliniken P&L

	FY 2023	FY 2024	FY 2025	LTM	NTM
Revenue	$324M	$360M	XXX	XXX	XXX
Gross Profit	$62.9M	$60.0M	XXX	XXX	XXX
Gross Margin	19%	17%	XXX	XXX	XXX
EBITDA	$19.5M	$26.3M	XXX	XXX	XXX
EBITDA Margin	6%	7%	XXX	XXX	XXX
Net Profit	$10.1M	$4.9M	XXX	XXX	XXX
Net Margin	3%	1%	XXX	XXX	XXX
Net Debt	n/a	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

M1 Kliniken Stock Performance

As of May 1, 2025, M1 Kliniken's stock price is EUR 16 (or $18).

M1 Kliniken has current market cap of EUR 309M (or $351M), and EV of EUR 296M (or $336M).

See M1 Kliniken trading valuation data

M1 Kliniken Stock Data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$336M	$351M	XXX	XXX	XXX	XXX	$1.01

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

M1 Kliniken Valuation Multiples

As of May 1, 2025, M1 Kliniken has market cap of $351M and EV of $336M.

M1 Kliniken's trades at 0.9x LTM EV/Revenue multiple, and 9.4x LTM EBITDA.

Analysts estimate M1 Kliniken's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See valuation multiples for M1 Kliniken and 10K+ public comps

M1 Kliniken Financial Valuation Multiples

	FY 2024	FY 2025E	FY 2026E	FY 2027E
EV	$336M	XXX	XXX	XXX
EV/Revenue	0.9x	XXX	XXX	XXX
EV/EBITDA	12.8x	XXX	XXX	XXX
P/E	30.0x	XXX	XXX	XXX
P/E/Growth	0.9x	XXX	XXX	XXX
EV/FCF	43.5x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get M1 Kliniken Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

M1 Kliniken Valuation Multiples

M1 Kliniken's NTM/LTM revenue growth is 7%

M1 Kliniken's revenue per employee for the last fiscal year averaged $1.6M, while opex per employee averaged $0.2M for the same period.

Over next 12 months, M1 Kliniken's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .

Analysts estimate M1 Kliniken's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See operational valuation multiples for M1 Kliniken and other 10K+ public comps

M1 Kliniken Operational Valuation Multiples

	FY 2024	NTM	FY 2025E	FY 2026E	FY 2027E
Revenue Growth	11%	XXX	XXX	XXX	XXX
EBITDA Margin	7%	XXX	XXX	XXX	XXX
EBITDA Growth	35%	XXX	XXX	XXX	XXX
Rule of 40 (SaaS-only)	15%	XXX	XXX	XXX	XXX
Revenue per Employee	$1.6M	XXX	XXX	XXX	XXX
Opex per Employee	$0.2M	XXX	XXX	XXX	XXX
S&M Expenses to Revenue	1%	XXX	XXX	XXX	XXX
G&A Expenses to Revenue	1%	XXX	XXX	XXX	XXX
R&D Expenses to Revenue	n/a	XXX	XXX	XXX	XXX
Opex to Revenue	11%	XXX	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Streaming Platforms

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Explore Valuation Multiples by Industry

Start Free Trial